HRP970200A2 - Novel carboxylic acid derivatives, their production and use - Google Patents

Novel carboxylic acid derivatives, their production and use

Info

Publication number
HRP970200A2
HRP970200A2 HR19614542.2A HRP970200A HRP970200A2 HR P970200 A2 HRP970200 A2 HR P970200A2 HR P970200 A HRP970200 A HR P970200A HR P970200 A2 HRP970200 A2 HR P970200A2
Authority
HR
Croatia
Prior art keywords
production
carboxylic acid
acid derivatives
novel carboxylic
novel
Prior art date
Application number
HR19614542.2A
Other languages
English (en)
Inventor
Wilhelm Amberg
Andreas Kling
Dagmar Klinge
Hartmut Riechers
Ernst Baumann
Liliane Unger
Manfred Raschack
Stefan Hergenroeder
Sabine Schult
Original Assignee
Basf Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Basf Ag filed Critical Basf Ag
Publication of HRP970200A2 publication Critical patent/HRP970200A2/xx

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D215/00Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
    • C07D215/02Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
    • C07D215/16Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D215/20Oxygen atoms
    • C07D215/22Oxygen atoms attached in position 2 or 4
    • C07D215/227Oxygen atoms attached in position 2 or 4 only one oxygen atom which is attached in position 2
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00Drugs for disorders of the urinary system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00Drugs for disorders of the urinary system
    • A61P13/12Drugs for disorders of the urinary system of the kidneys
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/12Antihypertensives
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D215/00Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
    • C07D215/02Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
    • C07D215/16Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D215/20Oxygen atoms
    • C07D215/22Oxygen atoms attached in position 2 or 4
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D239/00Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/02Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
    • C07D239/24Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
    • C07D239/28Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
    • C07D239/32One oxygen, sulfur or nitrogen atom
    • C07D239/34One oxygen atom
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D239/00Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/02Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
    • C07D239/24Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
    • C07D239/28Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
    • C07D239/46Two or more oxygen, sulphur or nitrogen atoms
    • C07D239/60Three or more oxygen or sulfur atoms

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Urology & Nephrology (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
HR19614542.2A 1996-04-12 1997-04-11 Novel carboxylic acid derivatives, their production and use HRP970200A2 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE19614542A DE19614542A1 (de) 1996-04-12 1996-04-12 Neue Carbonsäurederivate, ihre Herstellung und Verwendung

Publications (1)

Publication Number Publication Date
HRP970200A2 true HRP970200A2 (en) 1998-04-30

Family

ID=7791123

Family Applications (1)

Application Number Title Priority Date Filing Date
HR19614542.2A HRP970200A2 (en) 1996-04-12 1997-04-11 Novel carboxylic acid derivatives, their production and use

Country Status (23)

Country Link
US (1) US6103732A (no)
EP (1) EP0892788A1 (no)
JP (1) JP2000508325A (no)
KR (1) KR20000005366A (no)
CN (1) CN1216042A (no)
AR (1) AR006593A1 (no)
AU (1) AU711293B2 (no)
BG (1) BG63202B1 (no)
BR (1) BR9708614A (no)
CA (1) CA2250764A1 (no)
CO (1) CO4900038A1 (no)
DE (1) DE19614542A1 (no)
HR (1) HRP970200A2 (no)
ID (1) ID19050A (no)
IL (1) IL126026A0 (no)
NO (1) NO311802B1 (no)
NZ (1) NZ331704A (no)
PL (1) PL329240A1 (no)
SK (1) SK127698A3 (no)
TR (1) TR199802042T2 (no)
TW (1) TW419465B (no)
WO (1) WO1997038982A1 (no)
ZA (1) ZA973096B (no)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ID26234A (id) 1996-12-18 2000-12-07 Basf Ag Turunan-turunan asam karboksilat heterosiklik, pembuatan dan penggunaannya sebagai antagonis-antagonis reseptor endotelen
US6030975A (en) * 1997-03-14 2000-02-29 Basf Aktiengesellschaft Carboxylic acid derivatives, their preparation and use in treating cancer
ID25620A (id) * 1997-09-04 2000-10-19 Basf Ag Turunan-turunan asam karboksilat baru, pembuatannya dan penggunaannya sebagai campuran reseptor antagonis et a/et b
EP1498124B1 (en) * 1997-10-17 2007-07-04 Ark Therapeutics Limited The use of inhibitors of the renin-angiotensin system
US7566452B1 (en) 1999-05-04 2009-07-28 New York University Cancer treatment with endothelin receptor antagonists
EP1243262B1 (en) * 2001-03-20 2006-05-31 Schwarz Pharma Ag Novel use of a peptide class of compound for treating non-neuropathic inflammatory pain
DK1243263T3 (da) * 2001-03-21 2003-03-17 Sanol Arznei Schwarz Gmbh Hidtil ukendt anvendelse af en klasse af peptidforbindelser til behandling af allodyni eller andre forskellige typer af kronisk- eller fantomsmerte
MXPA06011937A (es) 2004-04-16 2007-01-26 Sanol Arznei Schwarz Gmbh Uso de compuestos peptidicos para la profilaxis y el tratamiento de dolor de cabeza cronico.
BRPI0514721A (pt) * 2004-08-27 2008-06-24 Sanol Arznei Schwarz Gmbh uso de compostos de peptìdeos para tratar dor de cáncer ósseo, dor induzida por quimioterapia e nucleosìdeo
EP1754476A1 (en) * 2005-08-18 2007-02-21 Schwarz Pharma Ag Lacosamide (SPM 927) for treating myalgia, e.g. fibromyalgia
US20070048372A1 (en) * 2005-08-18 2007-03-01 Srz Properties, Inc. Method for treating non-inflammatory osteoarthritic pain
US20070043120A1 (en) * 2005-08-18 2007-02-22 Bettina Beyreuther Therapeutic combination for painful medical conditions
KR20150003925A (ko) * 2006-06-15 2015-01-09 유씨비 파르마 게엠베하 상승적 항경련 효과를 갖는 약제학적 조성물

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2882195A (en) * 1994-06-27 1996-01-19 Ciba-Geigy Ag Pyrimidinyl- and triazinyl-oxy and thio-3-haloalkyl-propionic acid derivatives as herbicides

Also Published As

Publication number Publication date
NO984713L (no) 1998-10-09
BG102770A (en) 1999-11-30
IL126026A0 (en) 1999-05-09
NO984713D0 (no) 1998-10-09
CA2250764A1 (en) 1997-10-23
AR006593A1 (es) 1999-09-08
CN1216042A (zh) 1999-05-05
KR20000005366A (ko) 2000-01-25
NO311802B1 (no) 2002-01-28
TW419465B (en) 2001-01-21
AU711293B2 (en) 1999-10-07
EP0892788A1 (de) 1999-01-27
NZ331704A (en) 2000-06-23
BR9708614A (pt) 1999-08-03
JP2000508325A (ja) 2000-07-04
PL329240A1 (en) 1999-03-15
AU2636497A (en) 1997-11-07
BG63202B1 (bg) 2001-06-29
ID19050A (id) 1998-06-04
ZA973096B (en) 1998-10-12
SK127698A3 (en) 2000-03-13
CO4900038A1 (es) 2000-03-27
DE19614542A1 (de) 1997-10-16
TR199802042T2 (xx) 2000-09-21
WO1997038982A1 (de) 1997-10-23
US6103732A (en) 2000-08-15

Similar Documents

Publication Publication Date Title
PL332720A1 (en) Novel derivatives of piperydinketone carboxylic acids, their production and application
HU9602339D0 (en) Hydroxamic acid and carboxylic acid derivatives, process for their preparation and use thereof
HUP9901312A3 (en) Novel alfa-hydroxylic acid derivatives, their production and use
HUP9902645A3 (en) Fused-ring carboxylic acid derivatives
ZA973002B (en) Carboxylic acid derivatives medicaments comprising these compounds their use and processes for their production
HU9502684D0 (en) 2,9-diamino- and 2-amino-8-carbamoyl-4-hydroxy-alkane-carboxylic acid derivatives
EP0645391A3 (en) Aminobenzoic acid derivatives.
HRP970199A2 (en) New carboxylic acid derivatives, their production and use
HRP970200A2 (en) Novel carboxylic acid derivatives, their production and use
AU2537695A (en) Epoxysuccinic acid derivatives, their production and use
HUP0000084A3 (en) 3-alkoxyisoxazol-4-yl-substituted-2-amino carboxylic acid derivatives, their use and pharmaceutical compositions containing them
AU2406597A (en) Thienopyridine derivatives, their production and use
AU3695297A (en) Alfa-amino acid amides, preparation thereof and the therapeutical use thereof
HUP0000553A3 (en) Sixmembered nitrogencontained heteroaromatic carboxylic acid derivatives, pharmaceutical compositions containing them, and their use for producing pharmaceutical compositions
ZA967537B (en) Novel carboxylic acid derivatives, their preparation and use.
HUP0000498A3 (en) Novel calpaines, production and use thereof
AU4219397A (en) Novel protein, its production and use
AU688611C (en) New carboxylic acid derivatives, their preparation and their use
AU6280800A (en) Cycloalkylalkane carboxylic acid amides, the production and use thereof
AU669416C (en) Quinolonecarboxylic acid derivatives, their production and use
AU2974695A (en) Nor-alpha-transbergamotenones, their production and use
AU5527190A (en) Acetalically protected, enantiomer-pure alpha-arylalkane carboxylic acids, their production and use
ZA939691B (en) 2-amino-6,7-dihydroxy-4-thiaheptanoic acid derivatives production and use thereof
HU9303478D0 (en) N-substituated aza-bicycloheptane derivatives, their production and use
AU682218C (en) Tetrazole derivatives, their production and use

Legal Events

Date Code Title Description
A1OB Publication of a patent application
AIPI Request for the grant of a patent on the basis of a substantive examination of a patent application
ODBC Application rejected